Medite Cancer Diagnostics (Medite Cancer Diagnostics) 3-Year ROIIC % : 0.00% (As of Dec. 2017)

Medite Cancer Diagnostics 3-Year ROIIC % Chart

Medite Cancer Diagnostics Annual Data
	Trend	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17
3-Year ROIIC %		Get a 7-Day Free Trial					-	-	-	-	-

Medite Cancer Diagnostics Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
3-Year ROIIC %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medite Cancer Diagnostics's 3-Year ROIIC %

For the Medical Instruments & Supplies subindustry, Medite Cancer Diagnostics's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medite Cancer Diagnostics's 3-Year ROIIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medite Cancer Diagnostics's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Medite Cancer Diagnostics's 3-Year ROIIC % falls into.

Medite Cancer Diagnostics 3-Year ROIIC % Calculation

Medite Cancer Diagnostics's 3-Year ROIIC % for the quarter that ended in Dec. 2017 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.

Medite Cancer Diagnostics  (OTCPK:MDIT) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.

Medite Cancer Diagnostics 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Medite Cancer Diagnostics's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medite Cancer Diagnostics (Medite Cancer Diagnostics) Business Description